Mediation effect of antithrombin III between chronic renal insufficiency and coronary artery disease in T2DM patients

Author:

Sun Ruoyu1,Wang Shaohua1,Wang Zheng2,Wang Chenchen1,Xu Yanchao3,Yuan Yang1ORCID

Affiliation:

1. Southeast University Zhongda Hospital

2. Gansu Provincial Hospital

3. Zhejiang University

Abstract

Abstract Purpose:The study aimed to investigate the potential effect of Antithrombin Ⅲ between chronic renal insufficiency and coronary artery disease in T2DM patients. Methods:We collected data of T2DM patients hospitalized in ZhongDa Hospital affiliated with Southeast University. Relationships between renal function, Antithrombin Ⅲ, and coronary artery disease were explored using multivariate regression models. Multiplicative and additive interaction analysis was investigated. Bootstrap mediation analysis was utilized to investigate the role of Antithrombin Ⅲ. Results:A total of 4,238 patients were included, among which the coronary artery disease prevalence was 23.8%. Lower levels of renal function and Antithrombin Ⅲ were observed in patients with coronary artery disease (P<0.05). In adjusted models, each 10-unit increase in Antithrombin Ⅲ was associated with an 8.3% (95%CI: 3.2%~13.1%; P<0.05) decrease in coronary artery disease risk. Patients with low levels of both eGFR and Antithrombin Ⅲ were in the highest risk (OR=1.45; 95%CI: 1.10-1.90, P<0.05) of coronary artery disease, while no multiplicative and additive interaction effects were significant. Bootstrap mediation analysis estimated that Antithrombin Ⅲ mediated approximately 4.40% of the effect of chronic renal insufficiency on coronary artery disease risk. Conclusion:Antithrombin Ⅲ may serve as a mediator between chronic renal insufficiency and coronary artery disease, providing mechanistic insights into a new clinical observation.

Publisher

Research Square Platform LLC

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号  京ICP备18003416号-3